Cancer vaccine could be ready in MONTHS: Drug giant Merck teams with Moderna to develop shot for melanoma that uses patients’ own TUMORS

A cancer vaccine could be here in MONTHS: Drug giant Merck teams with Moderna to develop

The new shot — designed for people with high-risk melanoma — is in the second of three trials and a verdict on whether it works or not is expected within months. It harnesses mRNA technology that uses pieces of genetic code from patients’ tumors to teach the body to fight off the cancer. The vaccine is given to people post-surgery to prevent the tumor from returning, and it is tailored to each patient, meaning no two shots will be the same. This means it could be hugely expensive. Similar cancer vaccines being trialed cost around $100,000 to make each individual shot. Merck and Moderna will share the production and commercial costs and split the profits if it goes to market. The collaboration has got markets excited, sending Moderna’s shares soaring 16 per cent Wednesday.

READ MORE:  https://www.dailymail.co.uk/health/article-11311307/A-cancer-vaccine-ready-MONTHS-Drug-giant-Merck-teams-Moderna-develop-cancer-jab.html

 

%d bloggers like this: